Institutional dossier
The documented history of Generate Biomedicines: chronology, people, research, capital and compute, and governance. Every statement opens its source and its limits.
Records dated 2018 to 2026-02-26 · 0 undated
4 claims · 1 sources · 4 not editorially accepted. The counts describe this selection. They do not measure completeness or independent confirmation.
Scope, evidence and limits
Description: Generate:Biomedicines in some of its own texts.
The records are grouped automatically. No human inspection of the selected claims, source paths or framing is recorded for this dossier. Each source passage shows how it was checked.
The dossier is computed from existing records. It is not a continuous history of the institution, and a missing record does not mean that an event or relationship did not happen. The chronology uses the dates of events and reports, not the date the public could first have known of them. Later sources can describe earlier events.
Select any statement to see its exact claim, qualification, date note, evidence passage, location in the source, source version and review status. The description above is Selekoa’s stored description of the institution, based on these sources:
Chronology
Records about the institution itself and documented changes to its frameworks, by year. Expand a year to read the claims. People’s other institutional records and related documents have their own sections. Where a date gives only the year or month, the order within it is unknown.
2018Record year · 3 claims
- Generate Biomedicines' IPO prospectus (26 February 2026) states that the company was "founded in 2018 by Flagship Pioneering".Flagship Pioneering → formed → Generate BiomedicinesInspect claim & evidence ↗
Record about this institution · Stated in source · Supported
Qualification and date notes
Formation as stated by Generate; it is not evidence of Flagship's ownership share or control at any date, which is not recorded.
Year as stated by the prospectus.
- Generate Biomedicines' IPO prospectus (26 February 2026) states that "Flagship Pioneering founded Generate in 2018 as Flagship VL56, Inc."Generate Biomedicines → is stated to have been founded in → 2018 Inspect claim & evidence ↗
Record about this institution · Stated in source · Supported
Qualification and date notes
A year as stated; it does not establish a legal incorporation date or a complete founder roster.
Year as stated by the prospectus; no month or day is given. The prospectus adds that in 2019 Flagship VL56, Inc. was combined with explorations from Flagship VL57, Inc.
- Generate Biomedicines' IPO prospectus (26 February 2026) names Gevorg Grigoryan as its Co-Founder and Chief Technology Officer.Gevorg Grigoryan → co-founded → Generate BiomedicinesInspect claim & evidence ↗
Record about this institution · Stated in source · Supported
Qualification and date notes
Co-founding and title as the prospectus states them; the prospectus also names Flagship ("Flagship Pioneering") as founder. No complete founder roster is implied.
Founding year as stated in Generate's IPO prospectus of 26 February 2026 ("Flagship Pioneering founded Generate in 2018"); no month or day, and no separate date of Grigoryan's participation, is given.
2026Record year · 1 claims
- Generate Biomedicines' IPO prospectus (26 February 2026) names Michael Nally as its Chief Executive Officer and states that he joined the company in 2021.Michael Nally → held role at → Generate BiomedicinesInspect claim & evidence ↗
Record about this institution · Stated in source · Supported
Qualification and date notes
A historical role snapshot; the record does not establish when he became CEO or any later role.
A role stated in the prospectus of this date; the joining year as stated (2021) is not a tenure start for the CEO title.